CAS 461432-26-8
:Dapagliflozina
Descripción:
Dapagliflozina es un medicamento utilizado principalmente en el manejo de la diabetes mellitus tipo 2. Pertenece a la clase de fármacos conocidos como inhibidores del cotransportador de sodio-glucosa 2 (SGLT2), que actúan previniendo la reabsorción de glucosa en los riñones, promoviendo así su excreción en la orina y reduciendo los niveles de glucosa en sangre. La fórmula química de Dapagliflozina es C21H25ClO6S, y presenta un grupo sulfonilo, un grupo clorofenilo y una estructura similar a la glucosa que facilita su mecanismo de acción. Dapagliflozina se administra típicamente por vía oral y a menudo se prescribe en conjunto con otros agentes antidiabéticos para mejorar el control glucémico. Además de sus efectos reductores de glucosa, se ha asociado con la pérdida de peso y una reducción de la presión arterial. Los efectos secundarios comunes pueden incluir infecciones del tracto urinario e infecciones micóticas genitales debido al aumento de glucosa en la orina. En general, Dapagliflozina representa un avance significativo en el tratamiento de la diabetes, ofreciendo un enfoque único para el manejo de los niveles de azúcar en sangre.
Fórmula:C21H25ClO6
InChI:InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
Clave InChI:InChIKey=JVHXJTBJCFBINQ-ADAARDCZSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2
Sinónimos:- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
- (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-
- Bms-512148
- D-Glucitol, 1,5-Anhydro-1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-, (1S)-
- Dapagliflozin
- Dapagliflozin free base
- (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Filtrar por
Porcentaje de pureza
0
100
|
0
|
50
|
90
|
95
|
100
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
Dapagliflozin
CAS:Fórmula:C21H25ClO6Pureza:>95.0%(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:408.88(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol
CAS:Fórmula:C21H25ClO6Pureza:97%Forma y color:SolidPeso molecular:408.8726Ref: IN-DA0039GJ
1kgA consultar5gA consultar500gA consultar10mg27,00€50mg28,00€100mg49,00€250mg52,00€1g107,00€10g552,00€250g659,00€Dapagliflozin
CAS:Fórmula:C21H25ClO6Pureza:≥ 98.0% (dried basis)Forma y color:White to light-yellow powderPeso molecular:408.87Dapagliflozin (Standard)
CAS:Dapagliflozin (Standard) is the standard for Dapagliflozin (T2389). Dapagliflozin is a competitive sodium-glucose cotransporter 2 (SGLT2) inhibitor that can reduce renal glucose reabsorption and promote urinary glucose excretion. Dapagliflozin can also inhibit renal mesangial cell fibrosis by regulating the HO-1/TGF-β1/Smad2/3 axis, and is related to research on glucose transport, renal cell responses, and fibrosis signaling. Dapagliflozin can also be used in research on SGLT2 pharmacology and mechanisms of renal fibrosis-related pathways.Fórmula:C21H25ClO6Peso molecular:408.87Dapagliflozin
CAS:Stability Hygroscopic
Applications A sodium-glucose transporter 2 inhibitor.
References Kasichayanula, S. et al.: Diabetes, Obesity and Metabolism 13, 47 (2011)Fórmula:C21H25ClO6Forma y color:NeatPeso molecular:408.87Dapagliflozin
CAS:(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triolFórmula:C21H25ClO6Pureza:97%Peso molecular:408.87Dapagliflozin
CAS:Dapagliflozin (BMS-512148) is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity.Fórmula:C21H25ClO6Pureza:99.5% - 99.97%Forma y color:SolidPeso molecular:408.87Dapagliflozin - Bio-X ™
CAS:Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. It inhibits glucose reabsorption in the proximal tubule of the nephron and results in glycosuria, which helps to improve glycaemic control. Also, Dapagliflozin is used to lower the risk of sustained eGFR decline, end-stage renal disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease who are at risk of progression.Fórmula:C21H25ClO6Pureza:Min. 99 Area-%Forma y color:PowderPeso molecular:408.87 g/molDapagliflozin
CAS:Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. SGLT2 is located in the proximal convoluted tubule and when it is inhibited the reabsorption of glucose into the kidneys is prevented and instead glucose is excreted in the urine. As a result glucose levels are reduced. Dapagliflozin is metabolized into to its inactive metabolite 3-O-glucuronide by the UGT1A9 enzyme present in the liver and the kidneys. In addition, dapagliflozin has been shown to cause weight loss and decrease the risk of cardiovascular events such as congestive heart failure.Fórmula:C21H25ClO6Pureza:Min. 98 Area-%Forma y color:White Yellow PowderPeso molecular:408.87 g/mol
![(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol](https://static.cymitquimica.com/products/IN/thumb/DA0039GJ.jpg)
